A specific biomarker was discovered in 2004: a serum autoantibody immunoglobulin (IgG) against the aquaporin-4 (AQP4) water channel in the CNS, which was named AQP4-IgG or NMO-IgG1,4. This evidence concerns the gene AQP4 and neuromyelitis optica.